BHB
GILD icon

Bank Hapoalim BM’s Gilead Sciences GILD Stock Holding History

Bank Hapoalim BM’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,098
Closed -$392K – 183
2020
Q2 		$392K Buy
5,098
+1,585
+45% +$121K 0.09% 129
2020
Q1 		$263K Buy
+3,513
New +$243K 0.08% 138
2019
Q3 		– Sell
-3,924
Closed -$265K – 175
2019
Q2 		$265K Sell
3,924
-1,550
-28% -$102K 0.07% 142
2019
Q1 		$356K Sell
5,474
-515
-9% -$34.2K 0.09% 123
2018
Q4 		$375K Buy
5,989
+1,488
+33% +$104K 0.12% 116
2018
Q3 		$348K Sell
4,501
-745
-14% -$56.3K 0.08% 147
2018
Q2 		$372K Sell
5,246
-5,949
-53% -$420K 0.1% 137
2018
Q1 		$844K Sell
11,195
-10,067
-47% -$800K 0.22% 87
2017
Q4 		$1.52K Sell
21,262
-10,161
-32% -$772K 0.33% 60
2017
Q3 		$2.55M Buy
31,423
+651
+2% +$49.8K 0.58% 42
2017
Q2 		$2.18M Sell
30,772
-1,961
-6% -$130K 0.52% 43
2017
Q1 		$2.22M Sell
32,733
-3,896
-11% -$274K 0.52% 46
2016
Q4 		$2.62M Sell
36,629
-4,564
-11% -$339K 0.7% 36
2016
Q3 		$3.26M Buy
41,193
+58
+0.1% +$4.71K 0.77% 34
2016
Q2 		$3.43M Buy
41,135
+9,770
+31% +$867K 0.8% 35
2016
Q1 		$2.88M Sell
31,365
-3,279
-9% -$296K 0.68% 36
2015
Q4 		$3.51M Buy
34,644
+1,427
+4% +$148K 0.8% 33
2015
Q3 		$3.26M Buy
33,217
+1,594
+5% +$177K 0.76% 35
2015
Q2 		$3.7M Buy
31,623
+1,495
+5% +$163K 0.73% 33
2015
Q1 		$2.96M Buy
30,128
+735
+3% +$74.6K 0.54% 44
2014
Q4 		$2.77M Buy
29,393
+930
+3% +$96.2K 0.59% 36
2014
Q3 		$3.03M Sell
28,463
-4,690
-14% -$459K 0.71% 31
2014
Q2 		$2.75M Sell
33,153
-3,545
-10% -$276K 0.68% 34
2014
Q1 		$2.6M Sell
36,698
-2,180
-6% -$171K 0.71% 29
2013
Q4 		$2.92M Buy
+38,878
New +$2.71M 0.89% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bank Hapoalim BM's GILD Position: Q3 2020 in Review

Bank Hapoalim BM sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 5,098 shares — an estimated $392K sold.

Bank Hapoalim BM first reported a position in GILD in Q4 2013 and held it in 25 quarters. The position peaked at $3.7M in Q2 2015. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Bank Hapoalim BM reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Bank Hapoalim BM sold 5,098 Gilead Sciences shares in Q3 2020, an estimated $392K.
  • Bank Hapoalim BM first reported a position in Gilead Sciences in Q4 2013 and held it in 25 quarters.
  • Bank Hapoalim BM's Gilead Sciences position peaked at $3.7M in Q2 2015.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Bank Hapoalim BM's 13F filing for Q3 2020, filed 12 Nov 2020.